Studying the impact of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) on placental dysfunction and FGR in patients with connective tissue disorders could lead to targeted interventions [14,15]. The gene discussed is TNF; the disease is connective tissue disorder.